Skip to Main Content

FDA Grants Emergency Use Authorization For Quest Diagnostics’ New Method For COVID-19 Tests

  • July 30, 2020

Bloomberg Law (7/29, Balji, Subscription Publication) reports “Quest Diagnostics said the FDA has granted emergency use authorization for a new laboratory technique that speeds the process of extracting viral RNA from specimens and will enable the company to expand its daily capacity of COVID-19 molecular diagnostic tests on behalf of patients in the US.”
      CNBC (7/29, Feuer) also reports.